JP2025501473A5 - - Google Patents

Info

Publication number
JP2025501473A5
JP2025501473A5 JP2024534426A JP2024534426A JP2025501473A5 JP 2025501473 A5 JP2025501473 A5 JP 2025501473A5 JP 2024534426 A JP2024534426 A JP 2024534426A JP 2024534426 A JP2024534426 A JP 2024534426A JP 2025501473 A5 JP2025501473 A5 JP 2025501473A5
Authority
JP
Japan
Prior art keywords
amino acid
cas12b
engineered
acid residues
nuclease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024534426A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025501473A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/137920 external-priority patent/WO2023104185A1/en
Publication of JP2025501473A publication Critical patent/JP2025501473A/ja
Publication of JP2025501473A5 publication Critical patent/JP2025501473A5/ja
Pending legal-status Critical Current

Links

JP2024534426A 2021-12-09 2022-12-09 エンジニアリングされたCas12bエフェクタータンパク質及びその使用方法 Pending JP2025501473A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2021/136761 2021-12-09
CN2021136761 2021-12-09
PCT/CN2022/137920 WO2023104185A1 (en) 2021-12-09 2022-12-09 Engineered cas12b effector proteins and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2025501473A JP2025501473A (ja) 2025-01-22
JP2025501473A5 true JP2025501473A5 (cg-RX-API-DMAC7.html) 2025-12-17

Family

ID=86686936

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024534426A Pending JP2025501473A (ja) 2021-12-09 2022-12-09 エンジニアリングされたCas12bエフェクタータンパク質及びその使用方法

Country Status (5)

Country Link
US (1) US20250051742A1 (cg-RX-API-DMAC7.html)
EP (1) EP4444875A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025501473A (cg-RX-API-DMAC7.html)
CN (2) CN118339285A (cg-RX-API-DMAC7.html)
WO (1) WO2023104185A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022040909A1 (en) * 2020-08-25 2022-03-03 Institute Of Zoology, Chinese Academy Of Sciences Split cas12 systems and methods of use thereof
WO2025067403A1 (zh) * 2023-09-28 2025-04-03 上海天泽云泰生物医药有限公司 用于治疗血红蛋白疾病的组合物和方法
TW202521691A (zh) * 2023-10-06 2025-06-01 美商藍岩醫療公司 經工程化之v型rna可程式核酸內切酶及其用途
CN117487778A (zh) * 2023-10-31 2024-02-02 江南大学 一种全新的基于CRISPR-Cas12b的碱基编辑器的构建及其应用
WO2025096367A1 (en) * 2023-11-03 2025-05-08 University Of Florida Research Foundation, Inc. Thermostable and/or charge-engineered cas12a variants for nucleic acid detection
CN120330162A (zh) * 2023-12-06 2025-07-18 尧唐(上海)生物科技有限公司 一种Cas蛋白、包含其的CRISPR-Cas系统及其应用
WO2026008077A1 (en) * 2024-07-05 2026-01-08 Shanghai Vitalgen Biopharma Co., Ltd. Modified grna for gene editing using crispr/cas system
WO2026060637A1 (en) * 2024-09-20 2026-03-26 Shanghai Vitalgen Biopharma Co., Ltd. Engineered mrna for gene editing using crispr/cas12b

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3733842A4 (en) * 2017-12-27 2021-08-04 Institute Of Zoology, Chinese Academy Of Sciences GENOME EDITING SYSTEM AND PROCEDURE
PL3765615T3 (pl) * 2018-03-14 2023-11-13 Arbor Biotechnologies, Inc. Nowe enzymy i układy crispr ukierunkowane na dna
US20210292747A1 (en) * 2018-07-27 2021-09-23 The Regents Of The University Of Colorado, A Body Corporate Engineered chimeric nucleic acid guided nucleases compositions, methods for making, and systems for gene editing
CA3106035A1 (en) * 2018-08-07 2020-02-13 The Broad Institute, Inc. Cas12b enzymes and systems
EP3861112A4 (en) * 2018-10-04 2022-09-21 The Regents of the University of Colorado, A Body Corporate ENGINEERED CHIMERIC NUCLEIC ACID-GUIDED NUCLEAR CONSTRUCTS AND THEIR USES
CN114829595B (zh) * 2019-10-17 2026-05-29 成对植物服务股份有限公司 Cas12a核酸酶的变体及其制备方法和用途
WO2021178934A1 (en) * 2020-03-06 2021-09-10 Metagenomi Ip Technologies, Llc Class ii, type v crispr systems
CN113308451B (zh) * 2020-12-07 2023-07-25 中国科学院动物研究所 工程化的Cas效应蛋白及其使用方法
CN113151215B (zh) * 2021-05-27 2022-11-18 中国科学院动物研究所 工程化的Cas12i核酸酶及其效应蛋白以及用途
JP2024522112A (ja) * 2021-05-27 2024-06-11 中国科学院動物研究所 エンジニアリングされたCas12iヌクレアーゼ、エフェクタータンパク質及びその用途

Similar Documents

Publication Publication Date Title
JP7761294B2 (ja) 遺伝子編集における非意図的な変異の阻害
US20230091847A1 (en) Compositions and methods for improving homogeneity of dna generated using a crispr/cas9 cleavage system
US20240200044A1 (en) Evolution of talens
AU2021201257B2 (en) Cas9 variants and uses thereof
US20230132569A1 (en) DNase H Activity of Neisseria Meningitidis Cas9
JP7679311B2 (ja) プログラム可能塩基エディターシステムを用いた一塩基多型編集法
JP2025013768A (ja) プログラム可能塩基エディターシステムを用いて病原性変異を抑制する方法
JP6633524B2 (ja) 操作された転写活性化因子様エフェクター(tale)ドメインおよびその使用
KR20200121782A (ko) 아데노신 염기 편집제의 용도
KR20220150329A (ko) 클래스 ii, 타입 v crispr 시스템
KR20180069898A (ko) 핵염기 편집제 및 그의 용도
US20230095295A1 (en) Phi29 mutants and use thereof
US20220389418A1 (en) Rna-guided cas nucleases and uses thereof in diagnostics and therapy
CN114144519A (zh) 单碱基置换蛋白以及包含其的组合物
WO2021108501A1 (en) System and method for activating gene expression
WO2023196476A1 (en) Compositions and methods of prime editor guide rna/sequencing tag complexes
Rousseau et al. Transposition of IS 911
WO2025139809A1 (zh) Cas蛋白、组合蛋白、核酸分子、核糖核蛋白复合物、重组载体、转基因细胞及其应用
WO2024173573A1 (en) Crispr-transposon systems and components
JP2026515554A (ja) Crisprの干渉および活性化のための改善された方法および組成物
US20240287547A1 (en) Genetic modification
JP2025505212A (ja) プライム編集システムを用いたゲノム編集のプロセスで起こり得るオフターゲットを予測するための方法
EP4450634A1 (en) Method for detecting integration site
CN111690724B (zh) 一种检测双链断裂产生试剂活性的方法
WO2024235991A1 (en) Rna-guided nucleases and nucleic acid targeting systems comprising such rna-guided nucleases